(19)
(11) EP 1 196 437 A1

(12)

(43) Date of publication:
17.04.2002 Bulletin 2002/16

(21) Application number: 00947385.1

(22) Date of filing: 14.07.2000
(51) International Patent Classification (IPC)7C07K 14/245, C12N 15/31, A61K 39/00, C07K 16/12
(86) International application number:
PCT/US0019/277
(87) International publication number:
WO 0105/827 (25.01.2001 Gazette 2001/04)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 15.07.1999 US 144013 P

(71) Applicants:
  • MEDIMMUNE, INC.
    Gaithersburg, MD 20878 (US)
  • WASHINGTON UNIVERSITY
    St. Louis, MO 63110 (US)

(72) Inventors:
  • HULTGREN, Scott, J.
    Ballwin, MO 63021 (US)
  • LANGERMANN, Solomon
    Baltimore, MD 21215 (US)

(74) Representative: LOUIS, PÖHLAU, LOHRENTZ & SEGETH 
Postfach 3055
90014 Nürnberg
90014 Nürnberg (DE)

   


(54) Fima PILUS-BASED VACCINES